(Q40311477)

19 September 2017

title

New therapeutic possibilities for vein graft disease in the post-edifoligide era. (English)

1 reference

19 September 2017

1

1 reference

19 September 2017

Neil J Freedman

2

1 reference

19 September 2017

publication date

1 July 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

2

1 reference

19 September 2017

issue

4

1 reference

19 September 2017

page(s)

493-501

1 reference

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Peripheral arterial disease: identification and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Molecular regulation of vascular smooth muscle cell differentiation in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Genetic engineering of vein grafts resistant to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells reduces neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Chronic ACE Inhibition Reduces Intimal Hyperplasia in Experimental Vein Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Murine model of neointimal formation and stenosis in vein grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Smooth muscle progenitor cells in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-beta1 in healing rat vein grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Chemokines direct endothelial progenitors into tumor neovessels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

E2F and cell cycle control: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Molecular basis of restenosis and drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Potent inhibitory effect of sirolimus on circulating vascular progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

PDGF and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

LRP: role in vascular wall integrity and protection from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

PDGF receptor kinase inhibitors for the treatment of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Imatinib attenuates diabetes-associated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Accelerated arteriosclerosis of vein grafts in inducible NO synthase(-/-) mice is related to decreased endothelial progenitor cell repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

In vivo activity of nuclease-resistant siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Role of statin therapy in the coronary bypass patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

Transcription factor decoys: a new model for disease intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.4.493

21 January 2018

Identifiers

DOI

10.2217/14796678.2.4.493

1 reference

19 September 2017

1 reference